MedTrace Logo

Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH

NCT00490464 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 163

Last updated 2007-06-22

No results posted yet for this study

Summary

The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any procedures performed are experimental.

Conditions

  • Subarachnoid Hemorrhage
  • Intracerebral Hemorrhage

Interventions

DRUG

Nicardipine and Nipride

Sponsors & Collaborators

  • University of Illinois at Chicago

    lead OTHER

Principal Investigators

  • Ben Z Roitberg, MD · University of Illinois at Chicago, Department of Neurosurgery

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Completion
2007-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00490464 on ClinicalTrials.gov